Contamination Rate and Economic Evaluation for Repeated Use of Medicated Preservative-Free Unit-Dose Eye Drops

Author(s)

Tahoun A1, Zawara A1, Nour El-Din H2, Osman A3
1Newgiza University, Cairo, Egypt, 2Cairo University, Cairo, Egypt, 3Newgiza University, Cairo, GZ, Egypt

OBJECTIVES:

Preservative-free eye drops are usually single-dose vials so that it is recommended to discard the vial upon first use even if there is any remaining solution. This study aims to discuss the infection possibility of multiple uses of these eye drops and evaluate the economic impact of such action.

METHODS:

80 vials were divided into 4 equal groups, with one control group (c) and three groups. Volunteers resembled three different installation techniques to simulate using these eye drops in reality. The vials were then recapped and kept in the refrigerator for 24 hours. Next, the remaining solution in each vial was cultured as well as group C vials, and contamination and infection rates were compared between each group against the control group by using Fisher`s exact test. The infection probabilities were applied to a decision tree model to compare the cost of reusing the vials.

RESULTS:

pathogenesis rate relative to the control group for Group A was (4/20) (20%) P ≥ 0.10, while group B got only 1 out of 20 (5%) P ≥ 1.0, finally group D (5/20) (25%) P ≤ 0.04 and this was the only group that showed a significantly higher rate of pathogenicity as an indicator to the importance of the instillation technique. By applying this probability to a base case decision tree after considering possible diseases the cost saving ranged between 20.4 and 20.1 EGP (about 1.3 U$) over a 10-day period of outpatient treatment of the ophthalmic diseases.

CONCLUSIONS:

Reusing unit-does eye drops is associated with low infection possibilities using the proper instillation technique. Following this technique is associated with cost savings. Confirmation of these results are warranted studying real-actual patients with glaucoma.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

EE420

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Drugs

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×